相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Effect of S-1 Plus Oxaliplatin Compared With Fluorouracil, Leucovorin Plus Oxaliplatin as Perioperative Chemotherapy for Locally Advanced, Resectable Gastric Cancer A Randomized Clinical Trial
Jiren Yu et al.
JAMA NETWORK OPEN (2022)
Japanese gastric cancer treatment guidelines 2018 (5th edition)
GASTRIC CANCER (2021)
Analysis of the Survival Impact of Postoperative Chemotherapy After Preoperative Chemotherapy and Resection for Gastric Cancer
Justin A. Drake et al.
ANNALS OF SURGICAL ONCOLOGY (2021)
Modified ypTNM Staging Classification for Gastric Cancer after Neoadjuvant Therapy: AMulti-InstitutionalStudy
Qing Zhong et al.
ONCOLOGIST (2021)
Current treatment and recent progress in gastric cancer
Smita S. Joshi et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer
Yoon-Koo Kang et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
Feng-Hua Wang et al.
CANCER COMMUNICATIONS (2021)
The Effectiveness of Postoperative Chemotherapy on pT1bN0 and pT2N0 Gastric Cancer Patients with Risk Factors: An International Dual-Center Analysis
Kun Yang et al.
YONSEI MEDICAL JOURNAL (2021)
The postoperative part of perioperative chemotherapy fails to provide a survival benefit in completely resected esophagogastric adenocarcinoma
Leila Sisic et al.
SURGICAL ONCOLOGY-OXFORD (2020)
Varying practices in tumor regression grading of gastrointestinal carcinomas after neoadjuvant therapy: results of an international survey
Maria Westerhoff et al.
MODERN PATHOLOGY (2020)
Interpretation of the development of neoadjuvant therapy for gastric cancer based on the vicissitudes of the NCCN guidelines
Xian-Ze Wang et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2020)
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
Salah-Eddin Al-Batran et al.
LANCET (2019)
Recent eUpdates to the ESMO Clinical Practice Guidelines on hepatocellular carcinoma, cancer of the pancreas, soft tissue and visceral sarcomas, cancer of the prostate and gastric cancer
G. Pentheroudakis
ANNALS OF ONCOLOGY (2019)
Impact of ypT, ypN, and Adjuvant Therapy on Survival in Gastric Cancer Patients Treated with Perioperative Chemotherapy and Radical Surgery
Felipe Jose Fernandez Coimbra et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Long-term Oncological and Functional Outcomes of Chemoradiotherapy Followed by Organ-Sparing Transanal Endoscopic Microsurgery for Distal Rectal Cancer The CARTS Study
Rutger C. H. Stijns et al.
JAMA SURGERY (2019)
Prophylactic effect of neoadjuvant chemotherapy in gastric cancer patients with postoperative complications
Kojiro Eto et al.
GASTRIC CANCER (2018)
Adjuvant Chemotherapy vs Postoperative Observation Following Preoperative Chemoradiotherapy and Resection in Gastroesophageal Cancer A Propensity Score-Matched Analysis
Ali A. Mokdad et al.
JAMA ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Adjuvant chemotherapy provided survival benefit for stage T2N0 gastric cancer with high-risk factors
Z. Wang et al.
NEOPLASMA (2018)
Global chemotherapy development for gastric cancer
Kazuto Harada et al.
GASTRIC CANCER (2017)
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
E. C. Smyth et al.
ANNALS OF ONCOLOGY (2016)
Adjuvant Therapy Improves Survival for T2N0 Gastric Cancer Patients with Sub-optimal Lymphadenectomy
Haejin In et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Impact of postoperative chemotherapy in patients with locally advanced gastroesophageal adenocarcinoma treated with perioperative chemotherapy strategy
Guillaume Luc et al.
AMERICAN JOURNAL OF SURGERY (2015)
Long-term Survival Outcomes of Advanced Gastric Cancer Patients Who Achieved a Pathological Complete Response with Neoadjuvant Chemotherapy: A Systematic Review of the Literature
Haruhiko Cho et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Adjuvant or neoadjuvant therapy for operable esophagogastric cancer?
Sing Yu Moorcraft et al.
GASTRIC CANCER (2015)
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
P. van Hagen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
Marc Ychou et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)